ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 624,60
0,72%
Dow Jones
38 834,86
0,00%
DAX
18 147,28
0,44%
Brent Oil
84,79
0,11%
Bitcoin
66 015,72
1,61%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Emergent Biosolutions Inc (EBS)

  7. Emergent Biosolutions Inc (EBS) Actualités

EBS

Emergent Biosolutions (EBS)

Emergent Biosolutions Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:EBS
DateHeureSourceTitreSymboleSociété
20/06/202413h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
20/06/202413h00GlobeNewswire Inc.Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 MillionNYSE:EBSEmergent Biosolutions Inc
11/06/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
06/06/202415h02GlobeNewswire Inc.Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness DayNYSE:EBSEmergent Biosolutions Inc
04/06/202422h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EBSEmergent Biosolutions Inc
10/05/202413h17GlobeNewswire Inc.Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024NYSE:EBSEmergent Biosolutions Inc
01/05/202422h57GlobeNewswire Inc.Emergent BioSolutions Reports First Quarter 2024 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
01/05/202422h10GlobeNewswire Inc.Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial PositionNYSE:EBSEmergent Biosolutions Inc
01/05/202417h03GlobeNewswire Inc.Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to NaloxoneNYSE:EBSEmergent Biosolutions Inc
30/04/202423h26GlobeNewswire Inc.Emergent BioSolutions Announces Amendment to its Existing Credit FacilityNYSE:EBSEmergent Biosolutions Inc
22/04/202414h05GlobeNewswire Inc.Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024NYSE:EBSEmergent Biosolutions Inc
01/04/202414h00GlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNYSE:EBSEmergent Biosolutions Inc
28/03/202413h15GlobeNewswire Inc.Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid CrisisNYSE:EBSEmergent Biosolutions Inc
25/03/202413h05GlobeNewswire Inc.Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing FacilityNYSE:EBSEmergent Biosolutions Inc
08/03/202422h21Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:EBSEmergent Biosolutions Inc
06/03/202422h31GlobeNewswire Inc.Emergent BioSolutions Reports Fourth Quarter 2023 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
06/03/202412h02IH Market NewsU.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices ClimbNYSE:EBSEmergent Biosolutions Inc
29/02/202413h00GlobeNewswire Inc.Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024NYSE:EBSEmergent Biosolutions Inc
21/02/202413h00GlobeNewswire Inc.Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEONYSE:EBSEmergent Biosolutions Inc
09/01/202413h30GlobeNewswire Inc.Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024NYSE:EBSEmergent Biosolutions Inc
27/12/202312h08IH Market NewsWall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and MoreNYSE:EBSEmergent Biosolutions Inc
11/12/202323h22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:EBSEmergent Biosolutions Inc
11/12/202313h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:EBSEmergent Biosolutions Inc
28/11/202312h59GlobeNewswire Inc.Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)NYSE:EBSEmergent Biosolutions Inc
24/11/202313h30GlobeNewswire Inc.Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q FilingNYSE:EBSEmergent Biosolutions Inc
09/11/202322h22Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNYSE:EBSEmergent Biosolutions Inc
08/11/202323h38GlobeNewswire Inc.Emergent BioSolutions Reports Third Quarter 2023 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
30/10/202321h45GlobeNewswire Inc.UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023NYSE:EBSEmergent Biosolutions Inc
19/10/202312h30GlobeNewswire Inc.Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023NYSE:EBSEmergent Biosolutions Inc
16/10/202313h00PR Newswire (US)Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid EpidemicNYSE:EBSEmergent Biosolutions Inc
 Showing the most relevant articles for your search:NYSE:EBS

Dernières Valeurs Consultées

NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
EU
PX1
CAC 40
EU
BN
Danone
COIN
ETHUSD
Ethereum
EU
GLE
Societe Generale
EU
BNP
BNP Paribas
EU
CS
Axa
EU
LR
Legrand
EU
BEL20
Bel 20
EU
PX4
SBF 120
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés